National Guideline Clearinghouse | BSR and BHPR rheumatoid arthritis guidelines on safety of anti-TNF therapies.
March 11, 2013
New This Week
Guideline Title
BSR and BHPR rheumatoid arthritis guidelines on safety of anti-TNF therapies.
Bibliographic Source(s)
| Ding T, Ledingham J, Luqmani R, Westlake S, Hyrich K, Lunt M, Kiely P, Bukhari M, Abernethy R, Bosworth A, Ostor A, Gadsby K, McKenna F, Finney D, Dixey J, Deighton C, Standards, Audit and Guidelines Working Group of BSR Clinical Affairs Committee and BHPR. BSR and BHPR rheumatoid arthritis guidelines on safety of anti-TNF therapies. London (England): British Society for Rheumatology; 2010. 23 p. [206 references] |
Guideline Status
This is the current release of the guideline.
This guideline updates a previous version: Ledingham J, Deighton C. Update on the British Society for Rheumatology guidelines for prescribing TNF-α blockers in adults with rheumatoid arthritis (update of previous guidelines of April 2001). Rheumatology 2005;44: 157-63.
This guideline updates a previous version: Ledingham J, Deighton C. Update on the British Society for Rheumatology guidelines for prescribing TNF-α blockers in adults with rheumatoid arthritis (update of previous guidelines of April 2001). Rheumatology 2005;44: 157-63.
.png)
No hay comentarios:
Publicar un comentario